165 related articles for article (PubMed ID: 19100570)
1. Predictors of survival of advanced renal cell carcinoma: long-term results from Southwest Oncology Group Trial S8949.
Lara PN; Tangen CM; Conlon SJ; Flanigan RC; Crawford ED;
J Urol; 2009 Feb; 181(2):512-6; discussion 516-7. PubMed ID: 19100570
[TBL] [Abstract][Full Text] [Related]
2. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and prognosis of chromophobe non-metastatic renal cell carcinoma: a multicenter study.
Lee WK; Byun SS; Kim HH; Rha KH; Hwang TK; Sung GT; Lee W; Lim JS; Jeong YB; Kwon TG
Int J Urol; 2010 Nov; 17(11):898-904. PubMed ID: 20969636
[TBL] [Abstract][Full Text] [Related]
4. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
[TBL] [Abstract][Full Text] [Related]
5. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
[TBL] [Abstract][Full Text] [Related]
6. Concomitant intraoperative renal artery embolization and resection of complex renal carcinoma.
Lin PH; Terramani TT; Bush RL; Keane TE; Moore RG; Lumsden AB
J Vasc Surg; 2003 Sep; 38(3):446-50. PubMed ID: 12947251
[TBL] [Abstract][Full Text] [Related]
7. Outcomes following partial nephrectomy by tumor size.
Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
[TBL] [Abstract][Full Text] [Related]
8. Association of microvascular and capillary-lymphatic invasion with outcome in patients with renal cell carcinoma.
Eisenberg MS; Cheville JC; Thompson RH; Kaushik D; Lohse CM; Boorjian SA; Costello BA; Leibovich BC
J Urol; 2013 Jul; 190(1):37-43. PubMed ID: 23353044
[TBL] [Abstract][Full Text] [Related]
9. Limited prognostic value of tumor necrosis in patients with renal cell carcinoma.
Isbarn H; Patard JJ; Lughezzani G; Rioux-Leclercq N; Crépel M; Cindolo L; de la Taille A; Zini L; Villers A; Shariat SF; Bertini R; Karakiewicz PI
Urology; 2010 Jun; 75(6):1378-84. PubMed ID: 19781745
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
11. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.
Motzer RJ; Mazumdar M; Bacik J; Berg W; Amsterdam A; Ferrara J
J Clin Oncol; 1999 Aug; 17(8):2530-40. PubMed ID: 10561319
[TBL] [Abstract][Full Text] [Related]
12. Metastatic renal cell carcinoma risk according to tumor size.
Thompson RH; Hill JR; Babayev Y; Cronin A; Kaag M; Kundu S; Bernstein M; Coleman J; Dalbagni G; Touijer K; Russo P
J Urol; 2009 Jul; 182(1):41-5. PubMed ID: 19450840
[TBL] [Abstract][Full Text] [Related]
13. Renal cell carcinoma in young and old patients--is there a difference?
Thompson RH; Ordonez MA; Iasonos A; Secin FP; Guillonneau B; Russo P; Touijer K
J Urol; 2008 Oct; 180(4):1262-6; discussion 1266. PubMed ID: 18707708
[TBL] [Abstract][Full Text] [Related]
14. 10-year oncologic outcomes after laparoscopic and open partial nephrectomy.
Lane BR; Campbell SC; Gill IS
J Urol; 2013 Jul; 190(1):44-9. PubMed ID: 23306087
[TBL] [Abstract][Full Text] [Related]
15. Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma.
Saito K; Tatokoro M; Fujii Y; Iimura Y; Koga F; Kawakami S; Kihara K
Eur Urol; 2009 May; 55(5):1145-53. PubMed ID: 18930583
[TBL] [Abstract][Full Text] [Related]
16. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma.
Fujii Y; Saito K; Iimura Y; Sakai Y; Koga F; Kawakami S; Kumagai J; Kihara K
J Urol; 2008 Oct; 180(4):1290-5; discussion 1295-6. PubMed ID: 18707704
[TBL] [Abstract][Full Text] [Related]
17. Factors of importance for prediction of survival in patients with metastatic renal cell carcinoma, treated with or without nephrectomy.
Ljungberg B; Landberg G; Alamdari FI
Scand J Urol Nephrol; 2000 Aug; 34(4):246-51. PubMed ID: 11095082
[TBL] [Abstract][Full Text] [Related]
18. Comparative Survival following Initial Cytoreductive Nephrectomy versus Initial Targeted Therapy for Metastatic Renal Cell Carcinoma.
Bhindi B; Habermann EB; Mason RJ; Costello BA; Pagliaro LC; Thompson RH; Leibovich BC; Boorjian SA
J Urol; 2018 Sep; 200(3):528-534. PubMed ID: 29574109
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the UCLA Integrated Staging System and the Leibovich score in survival prediction for patients with nonmetastatic clear cell renal cell carcinoma.
Tan MH; Kanesvaran R; Li H; Tan HL; Tan PH; Wong CF; Chia KS; Teh BT; Yuen J; Chong TW
Urology; 2010 Jun; 75(6):1365-1370; 1370.e1-3. PubMed ID: 20022084
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors and analysis of S100a4 protein in resected pulmonary metastases from renal cell carcinoma.
Bandiera A; Melloni G; Freschi M; Giovanardi M; Carretta A; Borri A; Ciriaco P; Zannini P
World J Surg; 2009 Jul; 33(7):1414-20. PubMed ID: 19365673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
